Crystalys Therapeutics
3 clinical trials · Sponsor
◉ Watch Crystalys Therapeutics
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants (NCT07535034) | Crystalys Therapeutics | 2026-05-08 |
| A Study of Dotinurad Versus Allopurinol in Tophaceous Gout (NCT07089888) | Crystalys Therapeutics | 2025-08-04 |
| A Study of Dotinurad Versus Allopurinol in Participants With Gout (NCT07089875) | Crystalys Therapeutics | 2025-08-01 |
Track Crystalys Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.